Steve Miller is Chief Op. & Scientific Officer of CATALYST PHARMACEUTICALS, INC.. Currently has a direct ownership of 1.06 Million shares of CPRX, which is worth approximately $20.9 Million. The most recent transaction as insider was on Aug 13, 2021, when has been sold 40,963 shares (Common Stock, par value $0.001 per share) at a price of $6.09 per share, resulting in proceeds of $249,465. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.06M
11.58% 3M change
56.96% 12M change
Total Value Held $20.9 Million

Steve Miller Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 13 2021
SELL
Open market or private sale
$249,465 $6.09 p/Share
40,963 Reduced 5.52%
701,724 Common Stock, par valu...
Aug 13 2021
BUY
Exercise of conversion of derivative security
$202,800 $3.12 p/Share
65,000 Added 8.05%
742,687 Common Stock, par valu...
Dec 22 2020
BUY
Exercise of conversion of derivative security
-
20,000 Added 2.87%
677,687 Common Stock, par valu...
SM

Steve Miller

Chief Op. & Scientific Officer
Coral Gables, FL

Track Institutional and Insider Activities on CPRX

Follow CATALYST PHARMACEUTICALS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CPRX shares.

Notify only if

Insider Trading

Get notified when an Catalyst Pharmaceuticals, Inc. insider buys or sells CPRX shares.

Notify only if

News

Receive news related to CATALYST PHARMACEUTICALS, INC.

Track Activities on CPRX